1. Home
  2. GRDN vs PGEN Comparison

GRDN vs PGEN Comparison

Compare GRDN & PGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Guardian Pharmacy Services Inc.

GRDN

Guardian Pharmacy Services Inc.

HOLD

Current Price

$47.53

Market Cap

2.7B

ML Signal

HOLD

Logo Precigen Inc.

PGEN

Precigen Inc.

HOLD

Current Price

$6.97

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GRDN
PGEN
Founded
2004
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Retail-Drug Stores and Proprietary Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
2.2B
IPO Year
2023
2013

Fundamental Metrics

Financial Performance
Metric
GRDN
PGEN
Price
$47.53
$6.97
Analyst Decision
Strong Buy
Buy
Analyst Count
5
5
Target Price
$40.60
$8.33
AVG Volume (30 Days)
403.3K
4.1M
Earning Date
05-06-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.03
Revenue
$1,448,685,000.00
$230,981,000.00
Revenue This Year
N/A
$1,115.92
Revenue Next Year
$7.63
$81.04
P/E Ratio
$117.77
$228.33
Revenue Growth
17.93
N/A
52 Week Low
$23.18
$2.99
52 Week High
$47.02
$7.72

Technical Indicators

Market Signals
Indicator
GRDN
PGEN
Relative Strength Index (RSI) 76.93 52.26
Support Level $36.16 $6.60
Resistance Level $47.02 $7.30
Average True Range (ATR) 1.63 0.27
MACD 0.92 -0.09
Stochastic Oscillator 97.02 26.38

Price Performance

Historical Comparison
GRDN
PGEN

About GRDN Guardian Pharmacy Services Inc.

Guardian Pharmacy Services Inc is a pharmacy services company providing technology-enabled services to help residents of long-term health care facilities (LTCFs) adhere to appropriate drug regimens, reducing the cost of care and improving clinical outcomes. The Company provides high-touch clinical, drug dispensing, and administration services tailored to residents in assisted living facilities, behavioral health facilities, and group homes, while also serving residents in all types of LTCFs. It partners with residents, LTCFs, and health plan payors to help reduce errors in drug administration, manage drug regimens, and improve adherence. The Company derives its revenue mainly from the sale of pharmaceutical and medical products.

About PGEN Precigen Inc.

Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.

Share on Social Networks: